prix viagra 100mg http://kanab.utah.gov/aberad.php?pharmac... http://kanab.utah.gov/aberad.php?pharmac... prix viagra 25 viagra pas cher france achat viagra 50mg commande viagra mg ou se trouve le viagra le moins chere de france vente viagra en espesse acquisto cialis in italia cialis acquisto tadalafil senza ricetta venlafaxine pharmacie efavirenz compresse priligy mg
http://www.periodiques-caraibeamazonie.f... pharmacie en ligne pas cher pharmacie en ligne paris
  • kamagra günstig kaufen acquisto cialis originale on line france viagra
  • Cancer Prevention Research

    Mon, Nov 25, 2013

    Oral Cancer News

     

    Clinical and biochemical studies support smokeless tobacco’s carcinogenic potential in the human oral cavity

     
    Source: American Association of Cancer Research
    Published: November 9, 2013
    By: Susan R. Mallery, Meng Tong, Gregory C. Michaels, Amber R. Kiyani, and Stephen S. Hecht

     

    Abstract

    In 2007, International Agency for Cancer Research presented compelling evidence that linked smokeless tobacco use to the development of human oral cancer. While these findings imply vigorous local carcinogen metabolism, little is known regarding levels and distribution of Phase I, II and drug egress enzymes in human oral mucosa. In the study presented here, we integrated clinical data, imaging and histopathologic analyses of an oral squamous cell carcinoma that arose at the site of smokeless tobacco quid placement in a patient. Immunoblot and immunohistochemical (IHC) analyses were employed to identify tumor and normal human oral mucosal smokeless tobacco-associated metabolic activation and detoxification enzymes. Human oral epithelium contains every known Phase I enzyme associated with nitrosamine oxidative bioactivation with ~2 fold inter-donor differences in protein levels. Previous studies have confirmed ~3.5 fold inter-donor variations in intraepithelial Phase II enzymes. Unlike the superficially located enzymes in non-replicating esophageal surface epithelium, IHC studies confirmed oral mucosal nitrosamine metabolizing enzymes reside in the basilar and suprabasilar region which notably is the site of ongoing keratinocyte DNA replication. Clearly, variations in product composition, nitrosamine metabolism and exposure duration will modulate clinical outcomes. The data presented here form a coherent picture consistent with the abundant experimental data that links tobacco-specific nitrosamines to human oral cancer.

     

    * This news story was resourced by the Oral Cancer Foundation, and vetted for appropriateness and accuracy.

     

    Print Friendly
    Be Sociable, Share!
    , , ,

    Leave a Reply

    You must be logged in to post a comment.